Jeffrey will start with an overview followed by Bryan's detail of our Q4 and fiscal year 2025 results, as well as Q1 2026 guidance. This being his last conference call as CEO, after Q&A, we'll turn ...

Amgen Inc. delivered strong operational performance across the board in 2025, and you can see that in the breadth of our business. Three of these, Repatha, Evenity, and TestSpire, all grew by more ...

Digital Turbine (NASDAQ:APPS) reported $151.4 million in the fiscal third quarter ended Dec. 31, 2025, up 12% year over year, ...